House Budgeters Give FDA Device Center Slight Bump In 2018
Executive Summary
A US FDA funding bill approved by a House subcommittee would allot the agency's device activities a total of $487.8m for FY 2018, including user fees and budget appropriations. Overall, CDRH would see a slight, $67.2m bump in funding.
You may also be interested in...
US Congress Extends Funds For FDA, NIH, To Dec. 8 In Bill Linked To Hurricane Relief
On the heels of a White House agreement with congressional Democratic leaders, the Senate and House quickly passed a government continuing resolution funding US FDA, NIH and other agencies as part of a Hurricane relief and debt-ceiling package, giving lawmakers until Dec. 8 to hammer out a detailed spending plan for the government in 2018.
US FDA User-fee Bill Will Pressure Budget In 2023
A provision in the FDARA user-fee bill prevents FDA from spending user-fee revenue on building maintenance costs beginning in FY 2023, which could deter future recruitment and retention of the "world's best and brightest" scientists at FDA, House Energy and Commerce ranking member Frank Pallone says.
House Appropriators Will Tell US FDA 'Don't Finalize' LDT Guidance In 2018 Funding Bill
When the House Appropriations Committee takes up the US FDA funding bill for 2018, report language would "prevent the agency from finalizing a guidance on regulating laboratory developed tests," Rep. Rosa DeLauro said at a June 28 Ag/FDA subcommittee markup. The House bill, while maintaining FDA discretionary funding at its prior-year $2.8bn level, also fully appropriates user fee authorizations agreed to by Senate and House Committees in FDA Reauthorization bills in May and June, respectively.